Profiles

Keywords
Last Name
Institution

Christopher Coogan

Concepts (187)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urology
7
2019
16
3.110
Why?
Malpractice
5
2015
11
2.100
Why?
Prostatic Neoplasms
9
2019
135
1.490
Why?
Carcinoma, Squamous Cell
3
2019
193
1.260
Why?
Kidney Neoplasms
6
2018
109
1.190
Why?
Clinical Competence
2
2015
268
1.000
Why?
Prostate
6
2019
34
0.950
Why?
Urinary Bladder Neoplasms
3
2012
44
0.840
Why?
Testicular Neoplasms
4
2010
31
0.840
Why?
Ureteral Neoplasms
1
2019
8
0.820
Why?
Vena Cava, Inferior
1
2019
14
0.820
Why?
Carcinoma, Renal Cell
3
2018
76
0.790
Why?
SEER Program
4
2013
37
0.780
Why?
Ureteral Calculi
1
2018
5
0.780
Why?
Ureteroscopy
1
2018
8
0.780
Why?
Kidney Calculi
1
2018
8
0.770
Why?
Lymph Node Excision
4
2008
39
0.740
Why?
Prostatectomy
5
2012
24
0.740
Why?
Internship and Residency
2
2018
182
0.740
Why?
Nephrectomy
4
2018
46
0.730
Why?
Models, Educational
1
2017
39
0.710
Why?
Stents
1
2018
157
0.680
Why?
Penile Neoplasms
2
2008
4
0.630
Why?
Image-Guided Biopsy
3
2019
30
0.580
Why?
Humans
39
2019
29841
0.560
Why?
Male
30
2019
17153
0.520
Why?
Nephrons
1
2012
9
0.510
Why?
Neoplasms, Radiation-Induced
1
2012
16
0.500
Why?
Urologic Diseases
1
2011
5
0.490
Why?
Neoplasms, Second Primary
1
2012
41
0.490
Why?
Sarcoidosis
1
2011
15
0.480
Why?
Marital Status
1
2010
15
0.450
Why?
Insurance, Liability
1
2010
1
0.450
Why?
Middle Aged
21
2019
11053
0.450
Why?
Postoperative Complications
6
2018
1059
0.390
Why?
Aged
17
2018
9833
0.380
Why?
Ultrasonography
2
2019
198
0.350
Why?
Retrospective Studies
8
2018
3303
0.340
Why?
Liability, Legal
1
2006
7
0.330
Why?
Gene Expression Regulation, Neoplastic
2
2004
131
0.330
Why?
Adult
14
2018
9591
0.320
Why?
Biopsy, Needle
2
2005
119
0.320
Why?
Pneumothorax
1
2005
12
0.310
Why?
Magnetic Resonance Imaging
3
2019
1220
0.300
Why?
Unnecessary Procedures
1
2005
30
0.290
Why?
United States
5
2015
2402
0.290
Why?
Genes, erbB-2
1
2004
8
0.290
Why?
Female
11
2019
17657
0.290
Why?
Carcinoma, Transitional Cell
1
2004
21
0.280
Why?
Adenocarcinoma
2
2003
233
0.280
Why?
Receptor, ErbB-2
1
2004
49
0.280
Why?
Vesico-Ureteral Reflux
1
2003
7
0.270
Why?
Prostatic Intraepithelial Neoplasia
1
2003
1
0.270
Why?
Prostatic Hyperplasia
1
2003
13
0.260
Why?
Urinary Bladder
2
2004
21
0.260
Why?
Collagen
1
2003
111
0.260
Why?
Multivariate Analysis
4
2013
390
0.260
Why?
Genital Neoplasms, Male
1
2002
3
0.260
Why?
Seminal Vesicles
1
2002
4
0.260
Why?
Glycoproteins
1
2003
66
0.260
Why?
Rectum
3
2018
69
0.260
Why?
Neurilemmoma
1
2002
15
0.260
Why?
Follow-Up Studies
7
2018
2017
0.250
Why?
Proportional Hazards Models
3
2013
379
0.250
Why?
Adrenal Hyperplasia, Congenital
1
2001
4
0.240
Why?
Drug Resistance, Bacterial
2
2018
53
0.230
Why?
Kidney Transplantation
1
2003
143
0.230
Why?
Treatment Failure
2
2018
186
0.230
Why?
Carcinosarcoma
1
2000
4
0.230
Why?
Time Factors
3
2017
1894
0.230
Why?
Kidney Pelvis
1
2000
13
0.220
Why?
Germinoma
2
1996
3
0.220
Why?
Survival Rate
2
2012
464
0.210
Why?
Ultrasonography, Interventional
2
2018
73
0.200
Why?
Neoplasm Invasiveness
1
2019
104
0.200
Why?
Urinary Incontinence, Stress
1
1998
4
0.200
Why?
Osteomyelitis
1
1998
22
0.200
Why?
Fluoroquinolones
1
2018
24
0.200
Why?
Ovariectomy
1
2018
26
0.190
Why?
Sickle Cell Trait
1
1998
5
0.190
Why?
Phantoms, Imaging
1
2018
48
0.190
Why?
Surgical Procedures, Operative
1
1998
38
0.190
Why?
Hysterectomy
1
2018
17
0.190
Why?
Ureter
1
2018
25
0.190
Why?
Preoperative Period
1
2018
72
0.190
Why?
Biopsy, Large-Core Needle
1
2017
5
0.180
Why?
Renal Veins
1
2017
3
0.180
Why?
Urinary Catheterization
1
1997
5
0.180
Why?
Surgical Stapling
1
2017
9
0.180
Why?
Early Detection of Cancer
1
2018
91
0.180
Why?
Renal Artery
1
2017
10
0.180
Why?
Antibiotic Prophylaxis
1
2017
35
0.180
Why?
Amebiasis
1
1996
4
0.170
Why?
Fournier Gangrene
1
1996
2
0.170
Why?
Laparoscopy
2
2017
186
0.170
Why?
Penile Diseases
1
1996
7
0.170
Why?
Ultrasonography, Doppler, Color
1
1996
9
0.170
Why?
Risk Factors
3
2018
2549
0.160
Why?
Genital Diseases, Male
2
2011
6
0.160
Why?
Postoperative Care
1
1997
138
0.160
Why?
Self Report
1
2017
217
0.160
Why?
Surgical Wound Infection
1
2017
102
0.160
Why?
Cryosurgery
1
1995
30
0.160
Why?
Attitude of Health Personnel
1
2017
177
0.160
Why?
Incidence
4
2018
813
0.160
Why?
Combined Modality Therapy
2
2012
467
0.150
Why?
Penis
1
1996
64
0.150
Why?
Anti-Bacterial Agents
1
2018
401
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1997
408
0.150
Why?
Prostate-Specific Antigen
2
2005
19
0.140
Why?
Penile Induration
1
1996
91
0.140
Why?
Hernia, Inguinal
1
2013
22
0.140
Why?
Prognosis
3
2010
1025
0.140
Why?
Melanoma
1
2013
69
0.130
Why?
Aged, 80 and over
5
2018
5016
0.130
Why?
Comorbidity
3
2018
555
0.120
Why?
Lung Neoplasms
1
2018
744
0.120
Why?
Radiotherapy
1
2012
67
0.120
Why?
Neoplasm Staging
3
2018
503
0.120
Why?
Kidney
1
2013
205
0.120
Why?
Survival Analysis
1
2012
390
0.120
Why?
Tomography, X-Ray Computed
4
2018
869
0.110
Why?
Pyrimidines
1
2010
29
0.110
Why?
Rectal Neoplasms
1
2010
27
0.110
Why?
Gastrointestinal Stromal Tumors
1
2010
21
0.110
Why?
Kaplan-Meier Estimate
1
2010
226
0.110
Why?
Kidney Diseases
1
2011
143
0.100
Why?
Treatment Outcome
4
2017
3788
0.100
Why?
Piperazines
1
2010
97
0.100
Why?
Young Adult
2
2017
2198
0.100
Why?
Physical Examination
2
2005
111
0.090
Why?
Retroperitoneal Space
2
1997
14
0.090
Why?
Antineoplastic Agents
1
2010
314
0.090
Why?
Adolescent
4
1997
2591
0.080
Why?
Cystectomy
1
2006
11
0.080
Why?
Urination Disorders
1
2005
6
0.080
Why?
Pleura
1
2005
7
0.080
Why?
Auscultation
1
2005
7
0.080
Why?
Respiratory Sounds
1
2005
11
0.080
Why?
Case Management
1
2005
15
0.080
Why?
Radiography, Thoracic
1
2005
38
0.080
Why?
Catheterization, Central Venous
1
2005
44
0.070
Why?
Gene Amplification
1
2004
29
0.070
Why?
Intraoperative Complications
1
2005
75
0.070
Why?
In Situ Hybridization, Fluorescence
1
2004
43
0.070
Why?
Biopsy
2
2018
278
0.070
Why?
Sensitivity and Specificity
1
2005
592
0.070
Why?
Injections
1
2003
59
0.070
Why?
Androgen Antagonists
1
2003
4
0.070
Why?
Urinary Tract Infections
1
2003
32
0.070
Why?
Immunohistochemistry
1
2004
497
0.060
Why?
Length of Stay
1
2005
360
0.060
Why?
Tissue Donors
1
2003
71
0.060
Why?
Antibodies, Monoclonal
1
2003
309
0.060
Why?
Diagnosis, Differential
1
2003
466
0.060
Why?
Lymphatic Metastasis
2
1997
109
0.060
Why?
Neoplasm Proteins
1
2000
60
0.050
Why?
Education
1
2019
42
0.050
Why?
False Positive Reactions
1
2018
40
0.050
Why?
Neoplasm Grading
1
2018
54
0.050
Why?
Bacterial Infections
1
2018
70
0.050
Why?
Salvage Therapy
1
1997
39
0.050
Why?
Lung
1
2018
164
0.040
Why?
Microbial Sensitivity Tests
1
2017
111
0.040
Why?
Arteriovenous Fistula
1
2017
8
0.040
Why?
Ligation
1
2017
37
0.040
Why?
Urethra
1
1997
17
0.040
Why?
Pilot Projects
1
2018
425
0.040
Why?
Ejaculation
1
1996
7
0.040
Why?
Fertility
1
1996
15
0.040
Why?
Postoperative Period
1
2018
291
0.040
Why?
Spinal Nerve Roots
1
1996
29
0.040
Why?
Mediastinal Neoplasms
1
1996
14
0.040
Why?
Operative Time
1
2017
94
0.040
Why?
Impotence, Vasculogenic
1
1996
4
0.040
Why?
Practice Guidelines as Topic
1
2018
382
0.040
Why?
Patient Discharge
1
1997
154
0.040
Why?
Linear Models
1
2013
277
0.030
Why?
Benzamides
1
2010
14
0.030
Why?
Colectomy
1
2010
33
0.030
Why?
Neoadjuvant Therapy
1
2010
67
0.030
Why?
Risk Assessment
1
2013
794
0.030
Why?
Tissue and Organ Harvesting
1
2003
25
0.020
Why?
Predictive Value of Tests
1
2005
617
0.020
Why?
Age Factors
1
2005
912
0.020
Why?
Prospective Studies
1
2005
1809
0.010
Why?
Minimally Invasive Surgical Procedures
1
2003
288
0.010
Why?
Coogan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description